Your browser doesn't support javascript.
loading
Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
Mitjà, Oriol; Godornes, Charmie; Houinei, Wendy; Kapa, August; Paru, Raymond; Abel, Haina; González-Beiras, Camila; Bieb, Sibauk V; Wangi, James; Barry, Alyssa E; Sanz, Sergi; Bassat, Quique; Lukehart, Sheila A.
Afiliação
  • Mitjà O; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Division of Public Health, School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island,
  • Godornes C; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Houinei W; Disease Control Branch, National Department of Health, Port Moresby, Papua New Guinea.
  • Kapa A; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea.
  • Paru R; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea.
  • Abel H; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea.
  • González-Beiras C; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Lisbon Institute of Hygiene and Tropical Medicine, Lisbon, Portugal.
  • Bieb SV; Disease Control Branch, National Department of Health, Port Moresby, Papua New Guinea.
  • Wangi J; Office of the World Health Organization (WHO) Representative for Papua New Guinea, WHO, Port Moresby, Papua New Guinea.
  • Barry AE; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Sanz S; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Biostatistics Unit, Department of Public Health, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Bassat Q; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Paediatric Infectious Diseases Unit, Paediatric Department, Hospital
  • Lukehart SA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA.
Lancet ; 391(10130): 1599-1607, 2018 04 21.
Article em En | MEDLINE | ID: mdl-29428183
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bouba / Azitromicina / Doenças Transmissíveis Emergentes / Administração Massiva de Medicamentos / Antibacterianos Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bouba / Azitromicina / Doenças Transmissíveis Emergentes / Administração Massiva de Medicamentos / Antibacterianos Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article